The origin, progress, and application of cell-based cardiac regeneration therapy

Area of Science:

• Regenerative Medicine
• Cardiovascular Research
• Bioengineering

Background:

• Cardiovascular disease (CVD) poses a significant global health threat, with increasing incidence and younger patient demographics.
• Late-stage CVD involves irreversible cardiomyocyte loss, exceeding the body's natural repair capacity.
• Current clinical treatments, including drugs and mechanical support, fail to reverse disease progression.

Purpose of the Study:

• To investigate the origins of regenerated myocardium in animal models capable of heart regeneration.
• To explore cell therapy as a novel treatment strategy for CVD.
• To review advancements in cardiac regeneration through cell therapy and bioengineering.

Main Methods:

• Lineage tracing studies to identify the source of new cardiomyocytes.
• Analysis of adult stem cell differentiation and cell reprogramming for cardiomyocyte regeneration.
• Evaluation of non-cardiomyocyte paracrine signaling in promoting cardiomyocyte proliferation.

Main Results:

• Identified sources of newly generated cardiomyocytes in regenerative models.
• Demonstrated the potential of cell therapy to compensate for cardiomyocyte loss.
• Highlighted the role of bioengineering in advancing cardiac regeneration.

Conclusions:

• Cell therapy, through direct cardiomyocyte regeneration or indirect paracrine effects, shows promise for heart repair.
• Bioengineering offers new opportunities for developing effective cardiac regeneration strategies.
• Further research into cell therapy is crucial for clinical applications in ischemic heart diseases.